<--- Back to Details
First PageDocument Content
Medicinal chemistry / Model organisms / Drug discovery / Pharmaceutical industry / Pharmacology / Synthetic biology / Saccharomyces cerevisiae / Metabolism / Evolva Holding / Pharmaceutical sciences / Biology / Science
Date: 2014-09-22 03:25:24
Medicinal chemistry
Model organisms
Drug discovery
Pharmaceutical industry
Pharmacology
Synthetic biology
Saccharomyces cerevisiae
Metabolism
Evolva Holding
Pharmaceutical sciences
Biology
Science

SynBio Presentation J Heim

Add to Reading List

Source URL: plantpower.ku.dk

Download Document from Source Website

File Size: 14,08 KB

Share Document on Facebook

Similar Documents

SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa

DocID: 1voSH - View Document

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

THE SCIENCE OF BETTER MEDICINES The Harvard Program in Therapeutic Science (HiTS) is building partnerships and developing new ideas and technologies to advance drug discovery and precision medicine.

DocID: 1vnKo - View Document

Scientific Program conferenceseries.com 3rd International Conference and Expo on Drug Discovery & Designing

DocID: 1vngF - View Document

5th CDDD Meeting COMPUTATIONALLY DRIVEN DRUG DISCOVERY November 16-17, 2017 | IFOM, Milan - Italy

DocID: 1vkVj - View Document